Acute Stroke and Atrial Fibrillation: Risk of Incorrect NOAC Dosage When Estimating Renal Function From Plasma Creatinine Only

BACKGROUND: Cardioembolic stroke (CS) due to atrial fibrillation (AF) bears a high risk of unfavorable outcome. Treatment with a non-vitamin K antagonist oral anticoagulant (NOAC) reduces this risk. NOAC dosage occurs on a thin line during the acute phase of the stroke unit when the patient is threa...

Descripción completa

Detalles Bibliográficos
Autores principales: Amoey, Danial C., Thranitz, Julia, Münte, Thomas F., Royl, Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294157/
https://www.ncbi.nlm.nih.gov/pubmed/35865641
http://dx.doi.org/10.3389/fneur.2022.907912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294157/
https://www.ncbi.nlm.nih.gov/pubmed/35865641
http://dx.doi.org/10.3389/fneur.2022.907912

Ejemplares similares